Nurse Practitioner, Family · Pittsburgh, PA
NPI
1417531856
Since 2021
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
127 Anderson St Ste 101
Pittsburgh, PA, 15212
Phone (412) 515-0000
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,151
39 services
Medicare patients, 2024
24
Average age 51
Drug cost, 2024
$1.3M
117 prescriptions
Company payments, 2025
$39K
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kweilynn M Greene was code 99204 (office e&m - new), 16 times for 16 patients. In total Kweilynn M Greene billed 39 services in 4 codes, and Medicare paid $2,151.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99204 Office E&M - New | Office | 16 | 16 | $86.46 | $1,383 |
| 36415 Venipuncture Blood Collection | Office | 14 | 13 | $8.65 | $121 |
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 14 | 13 | $8.65 | $121 |
Medicare prescription drug claims, 2024
In 2024, the drug Kweilynn M Greene prescribed most often to Medicare patients was Epclusa (Sofosbuvir/Velpatasvir), with 39 prescriptions and refills. In total Kweilynn M Greene wrote 117 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Epclusa Sofosbuvir/Velpatasvir | 39 | 39 | 15 | $889K |
| Sofosbuvir-Velpatasvir Sofosbuvir/Velpatasvir | 28 | 28 | 13 | $209K |
| Descovy Emtricitabine/Tenofov Alafenam | 15 | 17 | Under 11 | $36K |
Brand drugs: 101 claims; generic drugs: 16 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kweilynn M Greene $39K ($39K in general payments such as food, travel and fees) from 4 companies. The largest payer was Gilead Sciences, Inc. with $35K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.